Geneos Wealth Management’s Axon Enterprise AXON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.01M | Buy |
2,370
+216
| +10% | +$112K | 0.02% | 509 |
|
|
2025
Q4 | $1.22M | Buy |
2,154
+251
| +13% | +$156K | 0.03% | 450 |
|
|
2025
Q3 | $1.37M | Sell |
1,903
-95
| -5% | -$72.1K | 0.03% | 417 |
|
|
2025
Q2 | $1.65M | Sell |
1,998
-2,136
| -52% | -$1.45M | 0.04% | 406 |
|
|
2025
Q1 | $2.17M | Buy |
4,134
+2,287
| +124% | +$1.34M | 0.03% | 470 |
|
|
2024
Q4 | $1.1M | Buy |
1,847
+1,594
| +630% | +$867K | 0.04% | 400 |
|
|
2024
Q3 | $101K | Buy |
253
+70
| +38% | +$24.1K | ﹤0.01% | 966 |
|
|
2024
Q2 | $53.8K | Hold |
183
| – | – | ﹤0.01% | 1044 |
|
|
2024
Q1 | $57.3K | Hold |
183
| – | – | ﹤0.01% | 1019 |
|
|
2023
Q4 | $47.3K | Sell |
183
-17
| -9% | -$3.83K | ﹤0.01% | 1083 |
|
|
2023
Q3 | $39.8K | Buy |
200
+3
| +2% | +$590 | ﹤0.01% | 1140 |
|
|
2023
Q2 | $38.4K | Sell |
197
-130
| -40% | -$26.9K | ﹤0.01% | 1160 |
|
|
2023
Q1 | $73.5K | Buy |
327
+28
| +9% | +$5.57K | ﹤0.01% | 942 |
|
|
2022
Q4 | $49.6K | Sell |
299
-35
| -10% | -$5.53K | ﹤0.01% | 1064 |
|
|
2022
Q3 | $38K | Sell |
334
-150
| -31% | -$17K | ﹤0.01% | 1108 |
|
|
2022
Q2 | $45K | Hold |
484
| – | – | ﹤0.01% | 1320 |
|
|
2022
Q1 | $66K | Sell |
484
-535
| -53% | -$73.4K | ﹤0.01% | 1244 |
|
|
2021
Q4 | $159K | Buy |
1,019
+385
| +61% | +$64.6K | 0.01% | 964 |
|
|
2021
Q3 | $113K | Sell |
634
-145
| -19% | -$26.3K | ﹤0.01% | 1116 |
|
|
2021
Q2 | $138K | Sell |
779
-914
| -54% | -$135K | 0.01% | 1022 |
|
|
2021
Q1 | $256K | Hold |
1,693
| – | – | 0.01% | 864 |
|
|
2020
Q4 | $118K | Buy |
1,693
+1,243
| +276% | +$143K | ﹤0.01% | 1061 |
|
|
2020
Q3 | $39K | Buy |
450
+100
| +29% | +$8.7K | ﹤0.01% | 1356 |
|
|
2020
Q2 | $33K | Sell |
350
-55
| -14% | -$4.45K | ﹤0.01% | 1398 |
|
|
2020
Q1 | $30K | Buy |
405
+50
| +14% | +$3.74K | ﹤0.01% | 1332 |
|
|
2019
Q4 | $25K | Hold |
355
| – | – | ﹤0.01% | 1583 |
|
|
2019
Q3 | $20K | Hold |
355
| – | – | ﹤0.01% | 1597 |
|
|
2019
Q2 | $22K | Sell |
355
-50
| -12% | -$3.26K | ﹤0.01% | 1579 |
|
|
2019
Q1 | $22K | Sell |
405
-100
| -20% | -$5.12K | ﹤0.01% | 1522 |
|
|
2018
Q4 | $21K | Sell |
505
-150
| -23% | -$7.78K | ﹤0.01% | 1474 |
|
|
2018
Q3 | $44K | Buy |
655
+305
| +87% | +$20.6K | ﹤0.01% | 1224 |
|
|
2018
Q2 | $22K | Sell |
350
-505
| -59% | -$27.3K | ﹤0.01% | 1397 |
|
|
2018
Q1 | $33K | Sell |
855
-8,275
| -91% | -$258K | ﹤0.01% | 1177 |
|
|
2017
Q4 | $241K | Sell |
9,130
-385
| -4% | -$9.25K | 0.02% | 484 |
|
|
2017
Q3 | $215K | Buy |
9,515
+410
| +5% | +$9.6K | 0.02% | 491 |
|
|
2017
Q2 | $228K | Buy |
+9,105
| New | +$223K | 0.02% | 465 |
|
Other funds holding AXON
VCM
VPM
Geneos Wealth Management's AXON Position: Q1 2026 in Review
Geneos Wealth Management increased its Axon Enterprise (AXON) stake by 10% in Q1 2026, buying an estimated $112K and bringing the position to 2,370 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #509.
Geneos Wealth Management first reported a position in AXON in Q2 2017 and has held it in 36 quarters since. The position peaked at $2.17M in Q1 2025. 1,048 funds tracked by Wall St. Rank hold AXON as of Q1 2026.
- Geneos Wealth Management held 2,370 shares of Axon Enterprise worth $1.01M as of Q1 2026.
- Geneos Wealth Management bought 216 Axon Enterprise shares in Q1 2026, an estimated $112K.
- Axon Enterprise made up 0.02% of Geneos Wealth Management's portfolio in Q1 2026, its #509 holding.
- Geneos Wealth Management first reported a position in Axon Enterprise in Q2 2017 and has held it in 36 quarters since.
- Geneos Wealth Management's Axon Enterprise position peaked at $2.17M in Q1 2025.
- 1,048 funds tracked by Wall St. Rank held Axon Enterprise as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.